IBM Watson Health chief leaves role
Deborah DiSanzo, who has served as general manager of IBM Watson Health since 2015, is stepping down from her position and heading to the strategy team for IBM Cognitive Solutions, according to STAT.
Deborah DiSanzo, who has served as general manager of IBM Watson Health since 2015, is stepping down from her position and heading to the strategy team for IBM Cognitive Solutions, according to STAT.
The entities will use analytics to identify when an MRI or X-ray machine needs assistance. A technician will then be informed that the device needs to be repaired or replaced.
Spokesman Doug Shelton verified that IBM's recent round of layoffs hit its Watson Health unit, but he did not specify how many individuals lost their jobs, according to The Herald Sun.
The American Medical Association has founded the Integrated Health Model Initiative, a collaborative that brings the healthcare and technology sectors together around a shared data model. Organizations such as Cerner and IBM have already signed on as participants.
IBM and the Juvenile Diabetes Research Fund are teaming up to pinpoint the factors that lead to the onset of type 1 diabetes in children.
In a CNBC interview, Chamath Palihapitiya, CEO and founder of Social Capital, shot down IBM and its Watson platform.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The 2017 IBM X-Force Threat Intelligence Index says the number of healthcare records decreased significantly in 2016.
"Competitive advantage in healthcare will not come from digitization," Rometty said. "It's going to come from cognitive." But there must be transparency.
Forces beyond healthcare, including the rapid development of emerging technologies, new thinking about how people work best and changing employee expectations, are reshaping how healthcare leaders approach their businesses.
Am I crazy or am I a futurist in the making? You decide!
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sunday evening, "60 Minutes" devoted half its show to artificial intelligence. About 12 minutes of that discussed healthcare, particularly cancer care, and Watson took center stage in a glowing segment.
IBM researchers are developing lab-on-a-chip technology as a first step to entering the liquid biopsy space that holds great potential in diagnosing cancer early.
Plus, it's time to rethink IoT security, while phablets drive mobile app engagement.
The yet-unnamed app, for iPhone and iPad, is intended to provide decision support — via the IBM Cloud — and assist in the selection of implantable intraocular lenses.
IBM and Pfizer will build a IoT ecosystem to measure the health and quality of life of Parkinson's patients.